NIH-funded research R01 grant

Understanding how mechanical ventilation harms the lungs

Official title: Dissecting the molecular mechanisms of lung injury during mechanical ventilation

Funded at Ohio State University · NIH-11014415 · Data updated 2026-11-12

This study is looking at how the machines that help people breathe when they have serious lung problems can sometimes cause more harm, and it aims to find out how this happens so that we can make breathing treatments safer for patients with acute respiratory distress syndrome (ARDS).

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startFebruary 15, 2021
Project endJanuary 31, 2026
Funding year2025
Award (this year)$550,898
NIH project number5R01HL142767-05
Project IDNIH-11014415 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with acute respiratory distress syndrome (ARDS) who require mechanical ventilation.

Less likely to help

Patients with mild respiratory issues that do not require mechanical ventilation may not benefit from this research.

What this research studies

This research investigates the harmful effects of mechanical ventilation on patients with acute respiratory distress syndrome (ARDS). It focuses on how mechanical forces during ventilation can cause additional lung injury, known as ventilator-induced lung injury (VILI). The study aims to uncover the molecular mechanisms behind this injury, particularly the role of a protein complex called mTORC1, which may be a potential target for new treatments. By exploring these mechanisms, the research seeks to improve care for patients undergoing mechanical ventilation.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that prevent lung injury in patients receiving mechanical ventilation.

How similar studies have gone: Previous research has shown that targeting molecular pathways like mTORC1 can be effective in reducing lung injury, suggesting a promising avenue for this study.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Englert, Joshua a — Ohio State University
  • Study coordinator: Englert, Joshua a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.